Current Clinical Trials

A clinical trial is a research study that is done to find out if medical treatments can improve people’s health. A medical treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers.  They are also called “participants.”  Clinical Trials FAQs.

Find a Clinical Trial

Therapeutic Area Condition Description  
Bleeding Disorders
Hemophilia A An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A. Learn More
  Congenital Fibrinogen Deficiency An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency  Learn More
  Von Willebrand Disease Study of Voncento® in Subjects With Von Willebrand Disease Learn More
  Hemophilia B 
A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B Learn  More
Immunoglobulins  Chronic Inflammatory Demyelinating Polyneuropathy Extension Study of Maintenance Treatment with Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Learn More 
  Primary Immune Deficiency  Study of Immune Deficiency Patients treated with Subcutaneous Immunoglobulin (IgPro20, Hizentra) on Weekly and Biweekly Schedules Learn More 
Therapeutic Proteins Other Inflammatory or immune system disorders Dose escalation, placebo-controlled phase 1 study to assess the safety and tolerability of CSL324 in healthy adults Learn More 
How to Enroll into a Study

Find out if enrolling in a clinical trial is right for you.

Learn More
Product Pipeline

Delve into our portfolio of new products, improved products and manufacturing expertise.

Learn More
Clinical Trials

Learn what a trial is and why it is important.

Learn More

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter